Related Experiment Videos
Atopic eczema complicated by systemic lupus erythematosus
Naoyuki Higashi1, Seiji Kawana
1Department of Dermatology, Nippon Medical School, 1-1-5, Sendagi, Bunkyo-ku, Tokyo, 1138603, Japan. ton@nms.ac.jp
European Journal of Dermatology : EJD
|November 11, 2005
Summary
Atopic eczema (AE) patients may develop systemic lupus erythematosus (SLE). Monitoring AE patients with positive autoantibodies for SLE is crucial.
Area of Science:
- Immunology
- Dermatology
- Rheumatology
Background:
- Atopic eczema (AE) is a common inflammatory skin condition.
- Systemic lupus erythematosus (SLE) is a chronic autoimmune disease.
- The co-occurrence of AE and SLE is rarely reported.
Observation:
- Two male patients, aged 25 and 27, with atopic eczema developed systemic lupus erythematosus.
- Both patients presented with positive antinuclear antibody (ANA) and specific autoantibodies (anti-ssDNA, anti-SSA, anti-RNP, anti-dsDNA).
- A review of 33 SLE patients revealed a 12% incidence of prior atopic eczema.
Findings:
- The study highlights a potential association between atopic eczema and the development of systemic lupus erythematosus.
- Elevated autoantibody levels in ANA-positive patients with AE warrant further investigation.
- Simultaneous occurrence of AE and SLE, though rare, has been observed.
Implications:
- Clinicians should consider screening for SLE in atopic eczema patients with positive autoantibodies.
- Long-term monitoring for SLE development is recommended for AE patients with positive autoantibodies.
- Further research is needed to elucidate the underlying mechanisms linking AE and SLE.